Alnylam Pharmaceuticals
ALNY
#660
Rank
NZ$51.92 B
Marketcap
$402.60
Share price
-8.38%
Change (1 day)
42.21%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company